Home > Blog > Success Rate of Acute Myeloid Leukaemia Treatment in India: A Complete, Data-Driven Guide

Success Rate of Acute Myeloid Leukaemia Treatment in India: A Complete, Data-Driven Guide

Filters & Insights

Discover the success rate of acute myeloid leukemia treatment in India, including survival outcomes, treatment costs, hospital comparison.

Acute Myeloid Leukaemia (AML) is a fast-progressing blood cancer that requires immediate, specialised care. Over the last decade, India has emerged as a trusted destination for AML treatment due to steadily improving survival rates, access to advanced therapies, and treatment costs that are significantly lower than those in Western countries.

Large tertiary cancer centres in India now report outcomes comparable to global benchmarks, especially for patients treated early and those eligible for bone marrow transplantation. This has positioned India as a preferred choice for both domestic and international AML patients.

This guide breaks down the success rate of acute myeloid leukaemia treatment in India, the clinical factors that influence outcomes, how costs compare globally, and why patients from the USA, UK, Australia, Canada and other countries choose India for AML care.

👉 Shifam Health helps AML patients connect with India’s leading hematologists and transplant centers for faster, affordable treatment.Connect with us for a free consultation!

Understanding Acute Myeloid Leukemia and Why Outcomes Depend on Early Care

AML develops when abnormal myeloid cells multiply rapidly in the bone marrow, crowding out healthy blood cells. Because of its aggressive nature, early diagnosis and risk-adapted treatment play a major role in survival.

India follows NCCN and ESMO-aligned protocols, using cytogenetic risk stratification and molecular profiling to tailor therapy from day one.

👉 With Shifam Health, patients receive guided treatment planning even before arriving in India.

Success Rate of Acute Myeloid Leukaemia Treatment in India

India’s AML outcomes now closely match global benchmarks, especially in high-volume tertiary cancer centers.

AML Treatment Success Rates by Age Group

Patient Group	Complete Remission Rate	5-Year Survival Rate
Children & Adolescents	70–80%	60–70%
Adults (18–60 years)	65–75%	45–55%
Elderly Patients (60+)	40–55%	20–30%

These results are driven by early induction chemotherapy, structured consolidation protocols, access to stem cell transplantation, and increasing use of targeted agents.

What Factors Improve AML Survival Rates in India?

Several key elements contribute to the strong success rate of acute myeloid leukemia treatment in India:

1. Risk-Adapted Therapy

Indian centers routinely perform cytogenetics, FLT3, NPM1, and IDH mutation testing to personalize treatment.

2. Bone Marrow Transplant Expertise

India is now a global leader in allogeneic stem cell transplantation, with outcomes comparable to the US and Europe.

3. Infection Control Protocols

Advanced isolation units and antimicrobial stewardship significantly reduce treatment-related mortality.

AML Treatment Options Available in India

Treatment Modality	Purpose
Induction Chemotherapy	Achieve remission
Consolidation Chemotherapy	Prevent relapse
Targeted Therapy	Mutation-specific control
Bone Marrow Transplant	Long-term cure in high-risk AML
Maintenance Therapy	Reduce recurrence

👉 Through Shifam Health, patients get fast-tracked access to complete treatment, from arrival to post follow up Care. Everything is handled by us.

Cost of Acute Myeloid Leukaemia Treatment in India vs Other Countries

Cost Comparison Table

Country	AML Treatment Cost (USD)
India	25,000 – 45,000
USA	180,000 – 300,000
UK	120,000 – 200,000
Germany	140,000 – 220,000
Singapore	90,000 – 150,000

India offers up to 80% cost savings without compromising clinical outcomes.

👉 Shifam Health provides transparent cost estimates before treatment begins.

Bone Marrow Transplant Success Rate for AML in India

Transplant Type	Success Rate
Matched Sibling Donor	65–75%
Matched Unrelated Donor	55–65%
Haploidentical Transplant	50–60%

Indian transplant centers now perform haploidentical transplants routinely, expanding donor availability.

Why International Patients Choose India for AML Treatment

Globally trained hematologists
High-volume leukemia centers
Affordable transplant programs
English-speaking medical teams
Dedicated international patient services

India treats thousands of AML patients from Africa, the Middle East, CIS countries, and Southeast Asia every year.

👉 Shifam Health manages visas, hospital coordination, and post-treatment follow-up.

Best Hospitals in India for AML Treatment

Hospital Type	Key Strength
Government Cancer Institutes	High experience, low cost
Private Tertiary Hospitals	Advanced diagnostics & comfort
Dedicated BMT Centers	High transplant volumes

India is home to some of the best hospitals in the world for Acute Myeloid Leukemia (AML) treatment, offering advanced oncology care, expert haematologists, and strong support for international patients. Hospitals like Tata Memorial Centre in Mumbai, Apollo Hospitals across major cities, Max Super Speciality Hospitals in Delhi and Gurgaon, and Fortis Memorial Research Institute in Gurugram are known for their dedicated leukemia units, modern chemotherapy protocols, bone marrow transplant facilities, and personalised patient care programs. These centers combine international standards of cancer treatment with highly skilled medical teams, multidisciplinary care, and supportive services that help patients and families navigate treatment with confidence and clarity.

Frequently Asked Questions (One-Liners)

Is AML curable in India?

Yes, many AML patients achieve long-term remission with chemotherapy and transplant.

How long does AML treatment take?

Initial treatment usually lasts 4–6 months, with follow-up therapy afterward.

Is bone marrow transplant safe in India?

Yes, Indian BMT centers follow global safety standards.

Can international patients stay long-term in India for AML care?

Yes, medical visas are extendable based on treatment needs.

Does age affect AML survival rates?

Yes, younger patients generally have better outcomes

Final Thoughts: Is India the Right Choice for AML Treatment?

The success rate of acute myeloid leukaemia treatment in India has improved dramatically due to precision diagnostics, advanced transplant programs, and strict adherence to global treatment protocols. When combined with affordability and experience, India stands out as a top destination for AML care worldwide.